X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27997) 27997
Publication (1886) 1886
Newspaper Article (591) 591
Newsletter (396) 396
Book Review (212) 212
Book Chapter (110) 110
Magazine Article (83) 83
Transcript (74) 74
Conference Proceeding (65) 65
Book / eBook (41) 41
Dissertation (23) 23
Trade Publication Article (22) 22
Web Resource (12) 12
Data Set (10) 10
Reference (7) 7
Paper (4) 4
Report (4) 4
Government Document (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22942) 22942
male (15477) 15477
female (15408) 15408
index medicus (12299) 12299
middle aged (11056) 11056
adult (8916) 8916
hemoglobin (8158) 8158
aged (7674) 7674
hypoglycemic agents - therapeutic use (6427) 6427
diabetes mellitus, type 2 - drug therapy (5583) 5583
endocrinology & metabolism (5138) 5138
diabetes (5017) 5017
glycated hemoglobin a - metabolism (4953) 4953
glycated hemoglobin a - analysis (4947) 4947
treatment outcome (4273) 4273
diabetes mellitus, type 2 - blood (3982) 3982
type 2 diabetes (3920) 3920
blood glucose - metabolism (3862) 3862
hemoglobins - analysis (3840) 3840
insulin - therapeutic use (3809) 3809
anemia (3675) 3675
animals (3661) 3661
adolescent (3349) 3349
care and treatment (3306) 3306
hemoglobins - metabolism (3080) 3080
risk factors (3068) 3068
insulin (2899) 2899
glucose (2825) 2825
glycosylated hemoglobin (2791) 2791
research (2782) 2782
analysis (2620) 2620
mellitus (2342) 2342
time factors (2330) 2330
health aspects (2307) 2307
child (2233) 2233
diabetes mellitus (2185) 2185
therapy (2181) 2181
retrospective studies (2128) 2128
blood glucose - analysis (2050) 2050
diabetes mellitus, type 1 - drug therapy (2047) 2047
hematology (2044) 2044
glycemic control (2039) 2039
patients (2012) 2012
medicine, general & internal (1986) 1986
mortality (1963) 1963
prospective studies (1930) 1930
erythropoietin - therapeutic use (1913) 1913
pharmacology & pharmacy (1906) 1906
medicine (1852) 1852
aged, 80 and over (1829) 1829
drug therapy, combination (1765) 1765
diabetes therapy (1760) 1760
body mass index (1726) 1726
double-blind method (1711) 1711
diabetes mellitus, type 1 - blood (1662) 1662
blood (1654) 1654
hypoglycemic agents - administration & dosage (1645) 1645
young adult (1633) 1633
research article (1610) 1610
follow-up studies (1608) 1608
blood glucose - drug effects (1589) 1589
drug therapy (1558) 1558
anemia - drug therapy (1556) 1556
clinical trials (1542) 1542
management (1508) 1508
risk (1493) 1493
diabetes mellitus, type 2 - complications (1475) 1475
disease (1473) 1473
studies (1439) 1439
medical research (1419) 1419
rats (1407) 1407
oncology (1401) 1401
blood pressure (1388) 1388
biomarkers - blood (1382) 1382
prevalence (1380) 1380
hypoglycemic agents - adverse effects (1351) 1351
insulin - administration & dosage (1324) 1324
hyperglycemia (1318) 1318
hematocrit (1297) 1297
child, preschool (1272) 1272
anemia - etiology (1269) 1269
erythropoietin (1260) 1260
metformin - therapeutic use (1257) 1257
surgery (1256) 1256
children (1254) 1254
complications (1242) 1242
metformin (1214) 1214
insulin resistance (1211) 1211
internal medicine (1185) 1185
multidisciplinary sciences (1155) 1155
double-blind (1149) 1149
dose-response relationship, drug (1139) 1139
urology & nephrology (1137) 1137
hypoglycemia (1121) 1121
diagnosis (1099) 1099
metabolism (1089) 1089
cancer (1084) 1084
dextrose (1073) 1073
medicine & public health (1072) 1072
pregnancy (1071) 1071
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (27) 27
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27909) 27909
German (425) 425
French (268) 268
Spanish (146) 146
Russian (124) 124
Japanese (85) 85
Chinese (79) 79
Italian (62) 62
Polish (44) 44
Czech (33) 33
Dutch (29) 29
Portuguese (23) 23
Swedish (21) 21
Hungarian (17) 17
Bulgarian (16) 16
Croatian (12) 12
Danish (12) 12
Finnish (11) 11
Ukrainian (11) 11
Korean (8) 8
Norwegian (8) 8
Serbian (8) 8
Hebrew (6) 6
Turkish (4) 4
Bosnian (3) 3
Icelandic (3) 3
Slovak (3) 3
Arabic (2) 2
Lithuanian (2) 2
Romanian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Clinical Nutrition, ISSN 0002-9165, 04/2016, Volume 103, Issue 4, pp. 1145 - 1161
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2011, Volume 33, Issue 7, pp. 793 - 811
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1594 - 1603
In this trial in previously untreated patients with HCV genotype 1 infection and no cirrhosis, high rates of sustained response were achieved with three new... 
TRIAL | MEDICINE, GENERAL & INTERNAL | PLUS SOFOSBUVIR | C VIRUS-INFECTION | GENOTYPE 1 INFECTION | DACLATASVIR | SIMEPREVIR TMC435 | HEPATITIS-C | INTERFERON-FREE | TREATMENT-NAIVE PATIENTS | PHASE 2B | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Viral Load | Young Adult | Ritonavir - adverse effects | Ritonavir - therapeutic use | Adult | Female | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Uracil - therapeutic use | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Drug Combinations | Uracil - analogs & derivatives | Dosage and administration | Research | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Ritonavir | Body weight | Diarrhea | Infections | Nausea | Proteinase inhibitors | Pruritus | Drug resistance | Patients | Genotype & phenotype | Cirrhosis | Sleep disorders | Hepatitis | Asthenia | Hemoglobin | Interferon | Drug dosages | Genotypes
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Diabetes and Metabolism, ISSN 1262-3636, 2011, Volume 38, Issue 2, pp. 89 - 101
Abstract Dipeptidyl peptidase-4 (DPP-4) inhibitors offer new options for the management of type 2 diabetes. Direct comparisons with active glucose-lowering... 
Internal Medicine | Endocrinology & Metabolism | Linagliptine | Sitagliptin | Type 2 diabetes mellitus | Review | Clinical trial-DPP-4 inhibitor | Vildagliptine | Saxagliptine | Diabète de type 2 | Inhibiteur de la DPP-4 | Alogliptin | Sitagliptine | Linagliptin | Vildagliptin | Alogliptine | Revue générale | Essai clinique | Saxagliptin | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | INITIAL COMBINATION THERAPY | RANDOMIZED CONTROLLED-TRIAL | BETA-CELL FUNCTION | DRUG-NAIVE PATIENTS | ADD-ON THERAPY | IMPROVES GLYCEMIC CONTROL | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | ELDERLY-PATIENTS | Metformin - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Glycated Hemoglobin A - drug effects | Male | Pyrazines - therapeutic use | Pyrrolidines - therapeutic use | Adamantane - therapeutic use | Female | Weight Gain - drug effects | Purines - therapeutic use | Sitagliptin Phosphate | Drug Therapy, Combination | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Dipeptides - therapeutic use | Uracil - therapeutic use | Clinical Trials as Topic | Diabetes Mellitus, Type 2 - blood | Piperidines - therapeutic use | Quinazolines - therapeutic use | Cost-Benefit Analysis | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - therapeutic use | Uracil - analogs & derivatives
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 2009, Volume 32, Issue 5, pp. 762 - 768
0.0001). beta-Cell function measures returned to pretreatment values in both groups after a 4-week off-drug period. A1C and body weight rose to pretreatment... 
NON-INFERIORITY | GLYCEMIC CONTROL | SULFONYLUREA | GLUCAGON-LIKE PEPTIDE-1 | EXENDIN-4 | BASAL INSULIN | GLUCOSE | ENDOCRINOLOGY & METABOLISM | SECRETION | MELLITUS | TWICE-DAILY EXENATIDE | Metformin - therapeutic use | C-Peptide - blood | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Exenatide | Female | Insulin - analogs & derivatives | Insulin Secretion | Body Mass Index | Hypoglycemic Agents - therapeutic use | Insulin-Secreting Cells - physiology | Insulin, Long-Acting | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Insulin-Secreting Cells - drug effects | Insulin Glargine | Arginine - pharmacology | Venoms - therapeutic use | Kinetics | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Peptides - therapeutic use | Index Medicus | Original Research | Hemoglobin A | Insulin/analogs & derivatives/secretion/therapeutic use | Blood Glucose/metabolism | Type 2/blood/drug therapy/physiopathology | MEDICIN OCH HÄLSOVETENSKAP | Diabetes Mellitus | Insulin-Secreting Cells/drug effects/physiology | Venoms/therapeutic use | Metformin/therapeutic use | Glycosylated/metabolism | Peptides/therapeutic use | Arginine/pharmacology | Hypoglycemic Agents/therapeutic use | C-Peptide/blood | MEDICAL AND HEALTH SCIENCES
Journal Article
Circulation: Heart Failure, ISSN 1941-3289, 01/2016, Volume 9, Issue 1
Background The prevalence of pre-diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known. We... 
heart failure | Clinical trial | diabetes mellitus | prognosis | treatment outcome | clinical trial | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | TOLERANCE | HEMOGLOBIN A(1C) | HOSPITALIZATION | INHIBITION | A1C | INSULIN-RESISTANCE | GLUCOSE | DYSFUNCTION | OUTCOMES | Diabetes Mellitus - blood | Single-Blind Method | Prevalence | Prospective Studies | Ventricular Function, Left | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Heart Failure - physiopathology | Aminobutyrates - adverse effects | Male | Heart Failure - blood | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Heart Failure - diagnosis | Diabetes Mellitus - diagnosis | Diabetes Mellitus - mortality | Prediabetic State - epidemiology | Heart Failure - mortality | Prediabetic State - blood | Risk Assessment | Comorbidity | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Biomarkers - blood | Heart Failure - drug therapy | Prediabetic State - mortality | Prediabetic State - diagnosis | Stroke Volume | Disease-Free Survival | Diabetes Mellitus - epidemiology | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Blood Glucose - metabolism | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Angiotensin Receptor Antagonists - adverse effects | 10093 | 10150 | 10094 | Original | glucose | hospitalization | inhibition | Klinisk medicin | dysfunction | Clinical Medicine | a1c | insulin-resistance | hemoglobin a(1c) | Cardiovascular System & Cardiology | predictor | cardiovascular risk | tolerance
Journal Article